Aktis Oncology, Inc. Common stock (AKTS) — Capital Reinvestment Ratio
Aktis Oncology, Inc. Common stock (AKTS) has a Capital Reinvestment Ratio of 0.19x as of December 2024, meaning it reinvests 0% of its operating cash flow ($14.76 Million) in capital expenditures ($2.86 Million). See AKTS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aktis Oncology, Inc. Common stock Capital Reinvestment Ratio (2024–2024)
This chart tracks Aktis Oncology, Inc. Common stock's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Aktis Oncology, Inc. Common stock (2024–2024)
Year-by-year Capital Reinvestment Ratio for Aktis Oncology, Inc. Common stock from 2024 to 2024. For live market cap and broader valuation context, see Aktis Oncology, Inc. Common stock (AKTS) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | $14.76 Million | $2.86 Million | — |